{"id":48475,"date":"2026-07-31T01:57:00","date_gmt":"2026-07-30T23:57:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=8186879284400b833cd0f849e9107e05"},"modified":"2026-07-31T01:57:00","modified_gmt":"2026-07-30T23:57:00","slug":"securities-fraud-investigation-into-alnylam-pharmaceuticals-inc-alny-announced-shareholders-who-lost-money-urged-to-contact-the-law-offices-of-frank-r-cruz","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=48475","title":{"rendered":"Securities Fraud Investigation Into Alnylam Pharmaceuticals, Inc. (ALNY) Announced \u2013 Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz"},"content":{"rendered":"

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz<\/a> announces an investigation of Alnylam Pharmaceuticals, Inc. (\u201cAlnylam\u201d or the \u201cCompany\u201d) (NASDAQ: ALNY<\/a>) on behalf of investors concerning the Company\u2019s possible violations of federal securities laws.<\/p><\/a><\/a>

IF YOU ARE AN INVESTOR WHO LOST MONEY ON ALNYLAM PHARMACEUTICALS, INC. (ALNY), CLICK <\/b>HERE<\/b><\/a> TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.<\/b><\/p>

What Is The Investigation About?<\/b><\/p>

On July 30, 2026, Alnylam announced second quarter 2026 financial results. Among other things, the Company reported it has \u201clowered our TTR product sales guidance<\/b><\/i> for full-year 2026 to reflect learnings from the initial phase of our launch in the evolving ATTR-CM market, in particular the normalization of growth in second line volume after satisfying pent-up demand from patients waiting for a new therapy<\/b><\/i>.\u201d As a result, the Company lowered its total projected TTR net product revenues by approximately $200 million.<\/b><\/i><\/p>

On this news, shares of Alnylam fell as much as $81.25 or 28.35% in intraday trading on July 30, 2026, thereby injuring investors.<\/p>

Contact Us To Participate or Learn More: <\/b>If you purchased Alnylam securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:The Law Offices of Frank R. Cruz,2121 Avenue of the Stars, Suite 800,Century City, California 90067Call us at: 310-914-5007Visit our website at: www.frankcruzlaw.com<\/a>.Email us at: info@frankcruzlaw.com<\/a>Follow us for updates on Twitter at twitter.com\/FRC_LAW<\/a>.<\/p>

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.<\/p>

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p> Contacts<\/b>

The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz310-914-5007fcruz@frankcruzlaw.com<\/a>www.frankcruzlaw.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces an investigation of Alnylam Pharmaceuticals, Inc. (\u201cAlnylam\u201d or the \u201cCompany\u201d) (NASDAQ: ALNY) on behalf of investors concerning the Company\u2019s possible violations of federal securi…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-48475","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/48475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=48475"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/48475\/revisions"}],"predecessor-version":[{"id":48476,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/48475\/revisions\/48476"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=48475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=48475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=48475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}